Shirley Owusu-Ofori Selected Research

Shirley Owusu-Ofori Research Topics

10	Infections 01/2022 - 03/2003
7	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 09/2012
4	Pneumococcal Infections 01/2021 - 09/2012
3	Malaria 04/2016 - 07/2013
2	Acquired Immunodeficiency Syndrome (AIDS) 02/2009 - 02/2006
2	Viremia 02/2009 - 09/2006
1	Shock 11/2018
1	Syphilis 02/2016
1	Parasitemia 01/2012
1	Liver Diseases (Liver Disease) 04/2009
1	Asymptomatic Infections 04/2009
1	Persistent Infection 06/2007

4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 03/2003
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 09/2012
4	Penicillins (Penicillin)FDA Link 01/2021 - 09/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 03/2003
3	RNA (Ribonucleic Acid)IBA 02/2009 - 02/2006
2	AntigensIBA 07/2013 - 12/2007
1	AntibodiesIBA 02/2016
1	Riboflavin (Vitamin B2)FDA LinkGeneric 08/2015
1	EnzymesIBA 07/2013
1	Merozoite Surface Protein 1 (MSA1)IBA 07/2013
1	Chloroquine (Aralen)FDA LinkGeneric 07/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2013
1	Alanine Transaminase (SGPT)IBA 04/2009
1	Immunoglobulin M (IgM)IBA 02/2009
1	Surface Antigens (Surface Antigen)IBA 02/2008
1	Anti-Idiotypic AntibodiesIBA 12/2007
1	HLA-B57 antigenIBA 06/2007
1	Immunoglobulin G (IgG)IBA 09/2006

6	Blood Transfusion (Blood Transfusions) 11/2018 - 05/2013
3	Splenectomy 11/2017 - 05/2013
3	Conservative Treatment 11/2017 - 05/2013
2	Antibiotic Prophylaxis 01/2021 - 10/2017
1	Therapeutics 04/2009